We previously reported that pretreatment with the potent antioxidant TEMPOL improves mitochondrial function and restores preconditioning in the aging heart. Because mitophagy is implicated in cardiac preconditioning and declines with age, this study was designed to investigate how age influences mitophagy in response to preconditioning and whether TEMPOL pretreatment improves it. Old (22-24 months) rats were pretreated with or without 4-week TEMPOL and compared with young (4-6 months) untreated rats. Cardioprotection induced by isoflurane (ISO) in vivo and in isolated cardiomyocytes in vitro was assessed following ischemia/reperfusion and simulated hypoxia/reoxygenation, respectively. Mitophagy was determined by comparing the levels/subcellular locations of key mitophagic markers using Western blotting and immunofluorescence techniques. ISO preconditioned the young but not old heart in vivo and in vitro. Aging impaired ISO-induced mitochondrial accumulation of PINK1 and Parkin, as well as mitochondrial ubiquitination, and baseline and ISO-induced autophagic flux assessed by LC3 puncta, membrane associated LC3-II and p62. Pretreatment with TEMPOL improved these processes and restored ISO preconditioning. Inhibition of autophagy abolished ISO-induced protection in cardiomyocytes from young and TEMPOL pretreated old rats. Thus, antioxidant pretreatment significantly improves mitophagic response to ISO in old myocardium, which may contribute to restoration of cardioprotection in senescent animals.
Cardiac preconditioning describes a phenomenon in which preexposure of the heart to brief episodes of ischemia/reperfusion (I/R) or to a variety of pharmacologic agents enhances tolerance to subsequent prolonged, potentially lethal, I/R. Experimental studies have demonstrated that cardiac preconditioning is a promising strategy to protect the heart against ischemia reperfusion injury; however, clinical studies have shown both positive and negative results (1) . The observed lack of protection of preconditioning in the negative studies can in part be attributed to the presence of different risk factors and comorbidities in the patients selected (1) . For example, aging is one of the major factors associated with impaired cardiac preconditioning. We and others have previously reported that older animals fail to benefit from anesthetic preconditioning, ischemic preconditioning (IPC), or pharmacological preconditioning including cyclosporine A (CsA), a mitochondrial permeability transition pore (mPTP) inhibitor and SB-216763, a GSK3β inhibitor (2-7). Oxidative stress is one of the hallmarks of aging and is implicated in the pathophysiology of cardiovascular diseases and cardiac I/R injury (8, 9) . We have recently demonstrated that 4-week pretreatment with a superoxide scavenger TEMPOL by intraperitoneal injection improved mitochondrial functions and restored cardiac preconditioning induced by isoflurane (ISO) and CsA in the aging rat heart, whereas acute pretreatment was ineffective (7) . Yet the mechanisms underlying pharmacologic preconditioning and how antioxidants restore preconditioning in old heart are poorly understood or unknown.
Because damaged mitochondria produce excessive amounts of reactive oxygen species (ROS) and release cell death pathway-associated proteins causing cell injury and death (10) , removal of the damaged mitochondria is critical to maintain homeostasis and protects cells from injury, especially during stress. Mitophagy is the process that selectively removes and degrades dysfunctional mitochondria via macroautophagy (hereafter referred to as autophagy) and has been shown to be protective in I/R (11) (12) (13) . Studies using genetic knockin and knockout animal models targeting key mitophagyrelated genes have demonstrated that enhancement of mitophagy protects myocardium from I/R injury, whereas, inhibition leads to an accumulation of dysfunctional mitochondria and increased mortality (11) (12) (13) . Although the mechanisms underlying cardiac preconditioning have not yet been adequately elucidated, increased mitophagic activity is associated with preconditioning (14) (15) (16) . Based on indirect evidence provided by lipofuscin and ROS studies in the aged heart, autophagy/mitophagy declines with age (17) leading to accumulation of dysfunctional mitochondria. The damaged mitochondria produce excessive ROS that in turn lead to cellular damage, possibly including the mitophagy machinery as well. Therefore, correction of redox status by chronic treatment with antioxidant should improve mitophagy and restore preconditioning. Here we utilized both in vivo and in vitro models of myocardial stress to test how age influences mitophagic response to ISO preconditioning and whether 4-week TEMPOL in vivo pretreatment improves it.
Materials and Methods
All experimental procedures and protocols used in this study were reviewed and approved by the Animal Care and Use Committee of the State University of New York Stony Brook. In addition, all procedures conformed to the Guiding Principles in the Care and Use of Animals of the American Physiological Society and were in accordance with the Guide for the Care and Use of Laboratory Animals.
Materials
TEMPOL (4-hydroxy TEMPO) and bafilomycin A1 (BAF) were purchased from Sigma (St Louis, MO). ISO was obtained from Baxter Healthcare Corporation (Deerfield, IL). The antibodies used were sourced as follows: for Western blot: Antibodies to PINK1 (ab23707) and Parkin (ab15945) were from Abcam (Cambridge, MA); antibodies to COX-IV (4859), SQSTM1/p62 (5114), and LC3A/B (4108) were from Cell Signaling (Danvers, MA); mono-polyubiquitinated conjugated mAb (BML-PW8810) was from ENZO (Farmingdale, NY). The antibodies used for IF staining were PINK1 (ab23707, Abcam), Parkin (NB100-91921, Novus, Littleton, CO), LC3A/B (4108, Cell Signaling), and COX-IV (4859, Cell Signaling).
Animal Care and TEMPOL Administration
Male Fischer 344 rats of the following age groups, 4-6 months and 22-24 months were obtained and housed in the Division of Laboratory Animal Resources until the day of study. Each rat was randomized to receive water or TEMPOL containing drinking water (2 mM) freshly prepared daily. The final dose of TEMPOL was administered 24 hours before the exposure of ISO and I/R.
General Preparation and Surgery Protocol
Surgery preparation was as described previously (7) . Anesthesia was induced by an intraperitoneal injection of sodium thiobutabarbital (120-135 mg/kg, Sigma-Aldrich) with additional maintenance doses as necessary. Rats were tested for the absence of pedal reflexes throughout the experimental protocol to ensure adequate anesthesia. They were placed on a heating pad to maintain the body temperature at 37 ± 0.2°C. The right carotid artery was cannulated to measure arterial blood pressure. A tracheotomy was performed and the animal's lungs were ventilated using a Harvard Apparatus model 638 rat ventilator. The surgery protocol was as described in our previous work (7) . In brief, the pericardium was opened and a 6-0 prolene suture (Ethicon) was placed around the proximal left anterior descending coronary artery. Coronary artery occlusion was introduced by clamping the snare onto the epicardial surface of the heart with a hemostat and was confirmed by the appearance of epicardial cyanosis. Reperfusion was achieved by loosening the snare and was verified by observing an epicardial hyperemic response. At the end of the experiment, the animal was euthanized with an overdose of sodium thiobutabarbital.
In Vivo Experimental Protocols
In vivo experiment protocols are illustrated in Figure 1A for both the mitophagy study and measurement of infarction sizes. In this protocol, male Fisher old (22-24 months) rats were pretreated with or without TEMPOL (2 mM in drinking water) for 4 weeks. Twenty-four hours before the experiment, no TEMPOL was given in the drinking water so as to not interfere with preconditioning. After 24 hours, the old, old pretreated with TEMPOL, and young (4-6 months) untreated rats were randomly divided into control and ISO preconditioning groups. Baseline systemic hemodynamic was recorded 30 minutes after instrumentation is completed and calibrated. In ISO preconditioning group, rats were exposed to 1.0 minimum alveolar concentration of ISO for 30 minutes followed by a 15-minute resting period after discontinuation of the volatile anesthetic to allow the end-tidal concentration of ISO to reach zero. Rats were euthanized by intraperitoneal injection of overdose of sodium thiobutabarbital (200 mg/kg, Sigma-Aldrich), and left ventricular tissues were then collected. Mitochondrial and cytosolic fractionation was performed, and samples were stored at −80°C for future use. In another set of experiments, after 30 minutes of ISO exposure followed by 15 minutes of washout, rats were subjected to cardiac I/R (30 min/120 min). Myocardial infarction sizes were measured as described in Measurement of Myocardial Infarction Size.
Measurement of Myocardial Infarction Size
In subsets of each in vivo group, myocardial infarction sizes were measured as previously described (2) . Briefly, at the end of each experiment, the left anterior descending coronary artery was re-occluded and patent blue dye was injected intravenously to stain the normal region of the left ventricle. The heart was rapidly excised, and six 1-to 2-mm cross-sections of the left ventricle were obtained using a scalpel. Both surfaces of the six sections were then scanned using an Epson 3200 photo scanner and analyzed using two-dimensional planimetry within MatLab software (MathWorks, Natick, MA) to determine the total weight of the areas at risk. Within 5 minutes of preparation, the scanned regions were incubated at 37°C for 15 minutes in 1% 2,3,5-triphenyltetrazolium chloride in 0.1 M phosphate buffer adjusted to a pH of 7.4. This process left the infarction area white. Each slice was weighed, and the slices were then rescanned on both sides. The total area of infarction was determined by two-dimensional planimetry as described earlier. Infarction size was expressed as the infarction weight divided by the total areas at risk weight and multiplied by 100 to determine the percent infarct (Infarct/areas at risk).
Isolation of Cardiomyocytes
Ventricular cardiomyocytes were obtained by enzymatic dissociation as previously described (18) with modifications. Briefly, after the animal was fully anesthetized, the aorta was cannulated and heart was perfused using a Langendorff retrograde perfusion system with oxygenized Krebs-Henseleit solution (pH 7.3) supplemented with (in mM) taurine 10, 2,3-butanedione monoxine 20, and collagenase type 2 (331 U/mg, Worthington; 2 and 4 mg/mL for young and old rat hearts, respectively) until the tissue felt spongy by touch (30-40 min) . The heart was removed and teased into small pieces by forceps and further broken down by pipetting up and down. Single cell suspensions were obtained by passing the isolated cardiomyocytes through a 200-µm filter. Cells were then gradually reintroduced with calcium at final concentration of 1.0 mM and cultured in M199 (Sigma M4530) supplemented with (in mM) carnitine 2, creatine 5, taurine 5, HEPES 10, blebbistatin 25, and 0.2% BSA on laminin (20 µg/mL) coated culture dishes or plates.
In Vitro Experimental Protocols
In vitro experiment protocols are illustrated in Figure 1B for both the mitophagy study and the assessment of cell injury. In this protocol, cardiomyocytes were isolated from old rats pretreated with or without TEMPOL for 4 weeks and young untreated rats. After overnight culture without any further treatment, cells were incubated with 1MAC equivalent of ISO (340 µM) in the culture medium for 30 minutes at 37°C followed by 15-min washout. Cells were then either collected for subcellular fractionation and Western blot analysis or fixed for IF staining of the key mitophagy proteins. In another set of experiments, cells were subjected to normoxia or simulated hypoxia/ reoxygenation (H/R, 60 min/120 min) after exposure to ISO. When late autophagy inhibitor BAF (100 nM) was deployed, it was added to the culture 195 minutes prior to ISO exposure and maintained throughout the rest of experiments ( Figure 1B ).
In Vitro Simulated Hypoxia/Reoxygenation
In vitro simulated hypoxia and reoxygenation (H/R) was introduced as described (14) . Briefly, cells were subjected to pre-equilibrated ischemia-mimetic solution containing (in mM) NaCl 125, KCl 8, 2-deoxyglucose 20, Na lactate 0.5, MgSO 4 1.25, CaCl 2 1.2, KH 2 PO 4 1.2, NaHCO 3 6.25, and HEPES 20 (pH 7.4), placed into an anaerobic gas generating pouch system (BD GasPak EZ), and cultured for 60 minutes. Reoxygenation was achieved by placing the cells under normoxia condition and culturing in pre-equilibrated reperfusion buffer containing (in mM) NaCl 110, KCl 4.7, MgSO 4 1.25, CaCl 2 1.2, KH 2 PO 4 1.2, NaHCO 3 25, HEPES 20, and glucose 5 (pH 7.4) for 120 minutes. Parallel normoxia controls were performed corresponding to each treatment.
Cytotoxicity Assay
Media collected from cells after 120-minute reperfusion were assayed for LDH release using a LDH Assay Kit (Sigma, TOX7) according to the manufacturer's instructions. Results were normalized to the total LDH for each sample after cells were lysed.
Cell and Tissue preparation

Cell fractionation
Cell fractionation was performed as described in (19) with modifications. Briefly, cells were harvested in hypotonic buffer containing (in mM) sucrose 250, KCl 10, MgCl 2 1.5, EDTA 1, EGTA 1, HEPES 20 (pH 7.5), and protease inhibitor cocktail (Calbiochem, EMD Millipore Corp, Billerica, MA). Cells were then disrupted by passing cells through a 26-gauge needle 30 times, and then through a 30-gauge needle 15 times in a microcentrifuge tube on ice. The mixtures were then spun at 600g for 10 minutes to eliminate the nuclear fraction and unbroken cells. This procedure was repeated once, and the supernatants were then spun at 10,000g for 15 minutes. The resulting supernatants were collected as crude soluble fraction. Pellets were further lysed in lysis buffer containing (in mM) Tris-HCl 20 (pH 7.4), NaCl 137, EDTA 1, NaVO 3 Na 4 1, NaF 100, PMSF 1, 1% Nonidet P-40, 10% glycerol, and a complete protease inhibitor cocktail and centrifuged at 10,000g for 10 minutes to obtain the final mitochondria-enriched fraction (heavy membrane fraction). Samples were stored at −80°C until use.
Tissue fractionation
Tissue fractionation was carried out as described (14) . Frozen left ventricular tissues were thawed on ice in mannitol-sucrose based buffer containing (in mM) mannitol 220, sucrose 70, EGTA 2, MOPS 5, pH 7.4, and protease inhibitor cocktail. The tissue was then minced and homogenized using a Polytron homogenizer (Kinematica, Bohemia, NY). The samples were centrifuged at 1,000g for 10 minutes at 4°C, and the crude supernatants were further centrifuged at 3,000g for 15 minutes at 4°C. The mitochondria-enriched pellet was designated as heavy membrane fraction and the supernatant as crude soluble fraction. Samples were stored at −80°C until use.
Western Blot Analysis
Protein levels in the samples collected from heart tissues and cells were measured by Pierce BCA protein Assay Kit (Thermo Scientific).
Samples were then resolved on 4-20% Tris-HCl Criterian Precast Gel (BioRad, Hercules, CA) and transferred to nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk in phosphate-buffered saline (PBS) and probed with primary antibody overnight at 4°C. The blots were then incubated with appropriate horseradish peroxidase-conjugated secondary antibodies for 1 hour at room temperature and visualized after incubation with chemiluminescence reagents (Santa Cruz, CA).
Immunofluorescence Staining
Cells grown on LAB-TEK 8-chambered coverglass (155411, Thermo Scientific, Rochester, NY) were fixed with 4% paraformaldehyde at room temperature for 15 min followed by incubation in cold 100% methanol at −20°C for 10 minutes. After three washes with PBS, samples were blocked and permeabilized by 10% normal goat serum plus 0.3% Triton X-100 and 0.3% glycine. After a brief wash, cells were incubated with primary antibodies in 5% goat serum overnight at 4°C and followed by incubation with fluorophore-conjugated secondary antibodies in PBS for 1 hour at room temperature. After washes, cells were incubated with DAPI at 1 µg /mL for 15 minutes at room temperature for identifying nucleus, then samples were examined and imaged using an Olympus confocal microscope (FV1000).
Analysis of Mitophagy
Induction of mitophagy was primarily determined by immunofluorescence and immunoblotting for PINK1 and Parkin mitochondrial accumulation and mitochondrial protein ubiquitination. Autophagy flux was assessed in the presence and absence of bafilomycin A1 as described (20) , by immunofluorescence for endogenous LC3 (microtubule-associated protein 1 light chain 3) and immunoblotting for membrane-bound LC3-II and p62 (p62/SQSTM1/sequestosome-1) in the mitochondria-enriched heavy membrane fractions. Densitometry analyses of Western blot images were performed by Scion Image software (Scion Corporation). Protein expression levels were normalized to mitochondrial marker COX-IV and presented as fold changes relative to the corresponding young untreated controls. IF staining of LC3-II puncta was analyzed by Image J software (NIH) and presented as percentage of total area of LC3 puncta to the area of the whole cell.
Statistical Analysis
The numbers of animals used were 5-7 per experimental group in the in vivo studies and 3 per group in the in vitro studies. Statistical analysis of data was performed with two-way or three-way analyses of variance followed by Tukey post tests using SigmaPlot software (version 12.5) (Systat Software Inc.). Changes were considered statistically significant when p values were less than .05.
Results
TEMPOL Restored Cardiac Preconditioning in Aged Hearts In Vivo and In Vitro
To study age-related changes in mitophagy and test their relationships to loss of preconditioning and restoration of cardioprotection by TEMPOL, we modified an in vitro cardiomyocyte model of preconditioning and hypoxia/reoxygenation injury to suit mechanistic studies. We validated these modifications by comparing in vivo and in vitro models as illustrated in Figure 1 . TEMPOL pretreatment was given in drinking water (2 mM) (21,22) for 4 weeks in both models and was withdrawn 24 hours before preconditioning. ISO provided cardioprotection in the young but not in the old heart, as assessed by the myocardial infarction size after I/R in vivo ( Figure 2A ) and by LDH release after H/R in vitro ( Figure 2B ). Four-week TEMPOL pretreatment restored cardioprotection by ISO in the old myocardium in vivo and to remarkably similar extents in the corresponding cultured old cardiomyocytes in vitro (Figure 2A and B). Our previously published and unpublished results showed that TEMPOL did not affect mitochondrial calcium uptake capacity, mPTP opening in response to ROS (7), and ISO preconditioning in the young myocardium (unpublished). Therefore, we did not include TEMPOL pretreated young animals in the current study.
TEMPOL Did Not Affect Mean Blood Pressure and Heart Rate In Vivo
As demonstrated in Table 1 , no differences in the baseline hemodynamics were observed among experimental groups (protocol shown in Figure 1A) . Moreover, ISO significantly decreased the mean arterial blood pressure and heart rate to a similar extent in all groups. There were also no differences in hemodynamics among groups during the washout or coronary artery occlusion. All mean blood pressures were significantly decreased during the first hour of reperfusion and further decreased during the second hour of reperfusion. These results are consistent with our previous findings (2,7).
TEMPOL Increased PINK1 and Parkin Mitochondrial Accumulation in Response to ISO in Aged Hearts In Vivo and In Vitro
PINK1/Parkin-dependent mitophagy is initiated by mitochondrial PINK1 stabilization, Parkin translocation, and subsequent mitochondrial protein ubiquitination (23) . Western blot analyses demonstrated that in vivo, ISO preconditioning increased mitochondrial PINK1 and Parkin levels and promoted mitochondrial protein ubiquitination in the young, but not in the old heart. Fischer 344 rats pretreated with or without TEMPOL (2 mM in drinking water) for 4 weeks and young (4-6 months) Fischer 344 untreated rats were used. (A) Rats were randomly selected as controls or exposed to ISO (1MAC) for 30 minutes followed by 15-minute washout. Rats were then subjected to cardiac I/R (30 min/120 min). Myocardial infarct sizes were measured. Data are presented as percentage of left ventricular area at risk; mean ± SEM, n = 6-7 rats per group. (B) Cardiomyocytes from these rats pretreated with or without TEMPOL were isolated and cultured overnight without any further treatment. The next day cells were then incubated with 1MAC equivalent of ISO (340 μM) in culture medium for 30 minutes followed by 15-minute washout. Cells were then subjected to normoxia or simulated hypoxia/reoxygenation (H/R, 60 min/120 min). Cell injury was measured by LDH release. Data are presented as fold change relative to corresponding normoxia controls; mean ± SEM, n = 3 rats per group, each contributing cardiomyocytes to four replicate cultures per condition. C = control; ISO = isoflurane; O = old; OT = old+TEMPOL; Y = young. *p < .05. **p < .01, ***p < .001.
TEMPOL pretreatment restored ISO-mediated changes in the old heart ( Figure 3) . Similar results were also observed in primary cultured cardiomyocytes in vitro (Figure 4) . Moreover, these changes in the intermediate marker levels in young cardiomyocytes, and old cardiomyocytes from TEMPOL pretreated rats were further enhanced by addition of a late-stage autophagy inhibitor, BAF (Figure 4) , suggesting that increased levels of mitochondrial PINK1 and Parkin as well as protein ubiquitination induced by ISO involved enhanced initiation of mitophagy rather than ISO-induced accumulation of these intermediates due to decreased rates of removal of end-stage products. Double immunofluorescence staining of PINK1 or Parkin with COX-IV, a mitochondrial marker, confirmed our findings. Incubation of cardiomyocytes with ISO increased both colocalization of PINK1 with COX-IV and Parkin with COX-IV in the perinuclear regions of cardiomyocytes isolated from the young and TEMPOL pretreated old rats (Supplementary Figure 1) . In the cardiomyocytes isolated from the untreated old rats, ISO failed to enhance co-localization of PINK1 or Parkin with mitochondria ( Supplementary Figure 1) .
TEMPOL Restored ISO-Induced Autophagic Activity in Aged Cardiomyocytes
LC3 plays a critical role in autophagosome formation (24) . Upon autophagy induction, proLC3 is cleaved into soluble form of LC3-I, and then further to form isolation membrane (phagophore, cupshaped early-stage autophagosome)-bound LC3-II. LC3-II associates with both the outer and inner membranes of the phagophore. Upon formation of autophagosome, LC3-II on the outer membrane is cleaved off, whereas, LC3-II on the inner membrane is trapped and degraded by lysosomal enzymes after fusion of autophagosome with lysosome. Thus, endogenous LC3 visualized by fluorescence microscopy as punctate structures primarily represent autophagosomes (20) . In the current study, determination of LC3 puncta by IF staining and membrane-associated LC3-II by Western blot was used to assess the level of autophagic intermediates (mainly autophagosomes). Autophagy is a dynamic, multistep process and therefore the accumulation of autophagosomes is not always indicative of an increase in autophagy. It may represent a disruption in autophagosome-lysosome fusion, and/or a reduction of lysosome enzyme activities (20) . Therefore, a late-stage autophagy inhibitor BAF was used to differentiate these possibilities. As shown in Figure 5A and B, ISO increased the number of LC3 puncta in the cardiomyocytes from the young and TEMPOL pretreated old rats. The levels of LC3 puncta were further increased in these cells in the presence of BAF. In contrast, cardiomyocytes from old rats not pretreated with TEMPOL demonstrated dramatically higher baseline levels of LC3 puncta that were not further increased by BAF. In these cells, ISO failed to show any effect. Consistent with these data, Western blotting of membrane-bound LC3-II produced similar results ( Figure 5C and D) . p62 has been shown to bind ubiquitinated mitochondria through its ubiquitin binding domain and to recruit the phagophore via an LC3 binding domain. p62 is degraded after fusion of autophagosome with lysosome (20) . Therefore, it is another parameter that can be used to determine the levels of autophagic intermediates. In addition, studies have shown that IPC promoted mitochondrial p62 translocation and mitophagy both in vivo and in vitro and that depletion of p62 attenuated mitophagy and abolished IPC (14) . In the current study, we have found that like the membrane-bound LC3-II, mitochondrial p62 was increased in response to ISO in the cardiomyocytes from the young and TEMPOL pretreated old rats. The levels of mitochondrial p62 were further increased in these cells in the presence of BAF. However, in the old cardiomyocytes from rats not pretreated with TEMPOL, the baseline levels of mitochondrial p62 were significantly higher and they were not further changed by either BAF or ISO ( Figure 5C and E). Data are presented as means ± SEM, n = 6-7 rats per group. *p < .05, versus corresponding baseline within the same group. Old rats were pretreated with or without TEMPOL for 4 weeks, and young untreated rats were randomly selected as control or exposed to ISO (1MAC) for 30 minutes followed by 15-minute washout. Left ventricular tissues were then collected, and Western blot analyses were performed using the mitochondria-enriched heavy membrane fractions (COX-IV as a marker). Cytosolic marker GAPDH was used as a quality control of extraction of mitochondria-enriched fractions. Protein expression levels were normalized to mitochondrial marker COX-IV and presented as fold changes relative to the corresponding young untreated controls. Data are presented as mean ± SEM, n = 5-6 rats per group. *p < .05, **p < .01, ***p < .001. C = control; ISO = isoflurane; O = old; OT= old + TEMPOL; Y = young.
Inhibition of Autophagy Abolished Cardioprotection Induced by ISO in Cardiomyocytes
In order to understand whether ISO-induced mitochondrial autophagy is associated with its cytoprotective action in cardiomyocytes in vitro, we used a late-stage autophagy inhibitor BAF (100 nM) to block autophagy and observed its effect on ISO preconditioning. Cardiomyocytes from young and TEMPOL pretreated old rats were isolated. BAF was added 195 minutes before ISO preconditioning and maintained in the culture throughout the rest of procedures, including 30 minutes of ISO, 15 minutes of washout, 60 minutes of hypoxia, and 120 minutes of reoxygenation. Cell injury was assessed by LDH release. As demonstrated in Figure 6 , inhibition of autophagy abolished ISO-induced cytoprotection in the cardiomyocytes from the young and TEMPOL pretreated old rats.
Discussion
Preconditioning protects the young adult myocardium from I/R injury, but this benefit is compromised in older adults (2) (3) (4) (5) . Accumulation of dysfunctional mitochondria and chronic oxidative stress are hallmarks of aging (25) and could underlie resistance to preconditioning. Therefore, reducing myocardial oxidative stress and improving mitochondrial health may restore cardioprotection in the senescent myocardium. We recently reported that a 4-week pretreatment with TEMPOL, potent lipophilic antioxidant, re-established effective cardiac preconditioning by ISO or CsA in the old rats (7). In the current study, it was confirmed that ISO protected the young but not old heart and that pretreatment with TEMPOL for 4 weeks via drinking water restored ISO preconditioning in the old heart (Figure 2A ). In addition, we established an in vitro ISO preconditioning and H/R injury model using cardiomyocytes isolated from the young and old adult rats and obtained similar results ( Figure 2B ). With respect to ISO preconditioning in the young cardiomyocytes, our findings were consistent with others' reports that ISO reduced H/R-induced injury in isolated young adult cardiomyocytes (26) . In their studies, ISO also inhibited H/R-induced excessive ROS production (26) . The aging myocardium is associated with an accumulation of dysfunctional mitochondria and increased ROS production (17) . Agerelated attenuation of ISO preconditioning has been reported in a H 2 O 2 stress model in isolated human atrial myocytes (5) . Here, using a clinically relevant H/R injury model in vitro, we are the first to report that aging impairs ISO preconditioning and that pretreatment with TEMPOL restores ISO preconditioning in the old cardiomyocytes in vitro.
Although the exact mechanisms of preconditioning remain to be fully elucidated, growing evidence points to an essential role for mitophagy (14, 15) . Generally, dysfunctional mitochondria are particularly susceptible to I/R-induced mPTP opening, calcium accumulation, and membrane potential collapse, leading to cardiomyocyte death (27, 28) . Mitophagy, the process to remove dysfunctional mitochondria, has been shown to play a protective role in I/R injury (11) (12) (13) and to be associated with cardiac preconditioning (14) (15) (16) . Studies using genetic knockout animal models targeting key mitophagy genes PINK1 Cardiomyocytes were isolated from the old rats pretreated with or without TEMPOL for 4 weeks and young untreated rats. After overnight culture without any treatment, BAF (100 nM) was added to the culture 195 minutes prior to ISO and maintained throughout the rest of procedures, including incubation of ISO (30 min) and washout (15 min) (protocol as shown in Figure 1B ). Cells were then collected, and Western blot analyses were performed using 15 μg of mitochondria-enriched heavy membrane (COX-IV as a marker) and cytosolic fractions (GAPDH as a marker). Protein expression levels were normalized to the mitochondrial marker COX-IV and presented as fold changes relative to the corresponding young untreated controls. Data are presented as mean ± SEM, n = 3 rats per group, each contributing cardiomyocytes to two replicate cultures per condition. *p < .05, **p < .01, ***p < .001. BAF = bafilomycin A1; C = control; ISO = isoflurane; O = old; OT = old + TEMPOL; Y = young.
or Parkin have demonstrated that enhancement of mitophagy protects the myocardium from I/R injury, whereas, inhibition of mitophagy leads to an accumulation of dysfunctional mitochondria and increased mortality (11) (12) (13) . Mitophagy has also been shown to be essential for IPC and simvastatin-mediated cardioprotection (14, 15) . IPC and simvastatin increased mitophagy by promoting mitochondrial Parkin translocation, LC3-I to LC3-II conversion and p62 expression, whereas ablation of Parkin in young mice abolished the cardioprotective effects of IPC and simvastatin (14, 15) . The underlying mechanisms are consistent with stimulation of mitophagy by preconditioning, which removes pre-existing dysfunctional mitochondria (29) (30) (31) and thereby prevents excessive ROS production during I/R or H/R.
Based on the indirect evidence provided by lipofuscin, as well as ROS studies in the aged heart, autophagy/mitophagy declines with age (17) . Consistent with this, our study demonstrated that ISO preconditioning activated PINK1/Parkin mitophagy pathway in the young but not in the old myocardium and that 4-week pretreatment of TEMPOL restored the responses (Figures 3-4) . In the few studies that have directly assessed autophagy in aged heart tissues, the results were inconsistent (32) . The autophagic marker LC3-II, assessed by Western blot, has been shown to increase (33) , decrease (34), or remain unchanged (35) in aged heart tissues compared with the young controls. The possible causes of these discrepancies may be differences in experimental design, species, and genetic backgrounds. In addition, these studies examined only the steady state levels of LC3-II, but did not include any assessments of cardiac autophagic Figure 1B ). Cells were then fixed for IF staining or collected for subcellular fractionation, isolation of the mitochondria-enriched heavy membrane fraction and Western blot. IF data are presented as percentage of total area of LC3 puncta to the area of the cell. Protein expression levels were normalized to the mitochondrial marker COX-IV and presented as fold changes relative to the corresponding young untreated controls. Cytosolic marker GAPDH was used as a quality control under the same condition shown in Figure 4D . Data are presented as mean ± SEM, n = 3 rats per group. BAF = bafilomycin A1. *p < .05, **p < .01, ***p < .001. C = control; ISO = isoflurane; O = old; OT = old + TEMPOL; Y = young. Figure 6 . Cardiomyocytes from young and TEMPOL pretreated old rats were isolated and cultured overnight without any further treatment. The next day, BAF (100 nM) was added to the culture 195 minutes prior to ISO and maintained throughout the rest of procedures, including ISO preconditioning (30 min), washout (15 min), and H/R (60 min/120 min) (protocol as shown in Figure 1B ). Cell injury was measured by LDH release. Data are presented as fold change relative to corresponding normoxia controls; mean ± SEM, n = 3 rats per group, each contributing cardiomyocytes to four replicate cultures per condition. BAF = bafilomycin A1; C = control; ISO = isoflurane; OT = old+TEMPOL; Y = young. *p < .05, **p < .01.
flux. In the current study, autophagic flux was determined by IF staining of LC3 puncta and Western blot analyses of membraneassociated LC3-II and p62, in the presence and absence of late-stage autophagy inhibitor BAF, which should cause accumulation of the preceding intermediates and block clearance of autophagosomes. Our results showed that ISO increased the numbers of LC3 puncta, levels of mitochondria-associated LC3-II and p62 in the cardiomyocytes from young and TEMPOL pretreated old rats and that these parameters were further increased in the cells in the presence of BAF (Figure 5 ), suggesting the increases in LC3 puncta, mitochondrial LC3-II and p62 by ISO were due to enhancement of formation of autophagosomes rather than inhibition of their clearance. In contrast, cardiomyocytes from old rats not pretreated with TEMPOL demonstrated dramatically higher baseline levels of LC3 puncta, mitochondrial LC3-II and p62 that were not further increased by either BAF or ISO (Figure 5 ), indicating a reduced baseline rate of autophagosome clearance as well as a failure of activation of autophagy in the old cardiomyocytes. These changes in mitophagic flux in aged heart may underlie accumulation of damaged mitochondria and increased ROS production (17, 36) leading to a decreased ability of cardiomyocytes to adapt to stress conditions, such as I/R injury (17) . Importantly, the efficacy of TEMPOL pretreatment to correct these defects and to restore the mitophagic/autophagic response to ISO suggests a potential mechanism for the restoration of ISO-induced cardioprotection by this potent antioxidant.
ISO preconditioning has been associated with activation of adenosine receptors, K ATP channels (37), Erk1/2 (38) as well as partial mitochondrial depolarization (39) (40) (41) and delayed of mPTP opening (39, 42) . ROS is one of the major contributors to the pathogenic mechanisms underlying of I/R injury (8, 9) . However, low levels of ROS generated in response to mild stress, such as preconditioning, are cardioprotective (8) . ISO increases ROS signaling (39) before I/R but inhibits ROS production in response to I/R and protects cell from injury (43) . A study on the role of ISO in regulating mitochondrial ROS production has revealed that the interaction of ISO with complex I of the electron transport chain is responsible for generation of signaling ROS. Moreover, ISO also attenuates damaging ROS production that occurs during reperfusion by inhibiting reverse electron flow (44) . ROS scavengers given shortly before ISO abolish ISO-induced cardioprotection in a rat I/R model (44) . One possible interpretation is that a transient ISO-induced rise in ROS production activates mitophagy/autophagy (45, 46) , which removes damaged proteins and pre-existing dysfunctional mitochondria (29) (30) (31) and thereby prevents excessive ROS production during the subsequent I/R insult. A recent in vitro study has confirmed that moderate levels of ROS, insufficient to induce cell death, specifically trigger mitophagy (47) . An important distinction between previous antioxidant work and our studies was that we used chronic TEMPOL pretreatment only-no TEMPOL was given for 24 hours preceding preconditioning and I/R injury. Acute TEMPOL treatment is cardioprotective (48) but is incapable of restoring preconditioning in the senescent myocardium (7) . By eliminating the interference between the antioxidant and the spike in ROS required for preconditioning, our current protocol has proven effective in protecting the aging rat heart from anticipated injury.
One possible underlying mechanism that could explain improved mitophagic/autophagic activity in response to ISO preconditioning by prolonged TEMPOL pretreatment could be that chronic oxidative stress in aging leads to damage of the mitophagic machinery itself and that 4-week TEMPOL pretreatment corrects the redox status. In a relatively healthier environment with low oxidative stress, the regenerated mitophagy-associated proteins may enhance the efficiency of the mitophagic machinery, removing a greater fraction of damaged mitochondria and thus, improving mitochondrial quality and function. This is supported by our previous findings that 4-week TEMPOL pretreatment significantly increased antioxidative enzyme MnSOD activity and decreased oxidative stress as detected by an increased ratio of GSH-to-GSSG in the old heart. Furthermore, TEMPOL improved mitochondrial function, including capacity of mitochondrial calcium uptake and mPTP opening time in response to ROS (7) .
Because mitophagy is implicated in cardiac preconditioning (14, 15) , failure of the mitophagic response to ISO preconditioning in aged myocardium may be one of the mechanisms leading to the loss of preconditioning. Indeed, blocking mitophagy/autophagy by BAF abolished ISO-induced cytoprotection in cardiomyocytes from the young and TEMPOL pretreated old rats in vitro ( Figure 6 ). Although inhibition of mitochondrial autophagy by BAF is general and is not as specific as more precise genetic approaches, it confirms the role of mitophagy/autophagy in ISO preconditioning in the young cardiomyocytes and also suggests that improvement of mitophagic/autophagic activity by pretreatment of TEMPOL may be one of the underlying mechanisms by which TEMPOL restores the preconditioning.
In addition to measurement of the extent of cardiac tissue injury, hemodynamics at baseline, during ISO preconditioning, as well as subsequent occlusion of coronary artery and reperfusion were also monitored in our study (Table 1) . It is interesting to see that: first, neither age nor TEMPOL affected cardiac function, in terms of mean arterial blood pressure and heart rate, under the baseline or stress conditions; second, ISO temporarily decreased blood pressure and heart rate, to a similar extent, in all groups regardless of whether it protected cardiac injury or not; third, I/R caused a comparable significant reduction in the mean arterial blood pressure in all groups regardless of the damage size induced. These data suggest that cardiac function, as reflected by mean systemic blood pressure and heart rate, was not deficient in male 22-to 24-month-old Fischer 344 rats and that TEMPOL pretreatment and ISO exposure did not affect it. These results are consistent with our and others' previous findings (7, (49) (50) (51) .
There are several limitations of this study. First, only a single antioxidant was investigated. TEMPOL is a redox-cycling nitroxide that promotes the metabolism of many ROS (52) . The advantage of TEMPOL is not only its potent catalytic action but also its high membrane permeability that enables TEMPOL to be absorbed through gastrointestinal tract and to enter the cells and organelles, such as mitochondria (52) . TEMPOL also has been studied extensively in various animal models of oxidative stress (52) . By contrast, vitamins C and E or analogs demonstrate low efficacy in inhibiting O 2 − production in vascular smooth muscle cells (53) . Other potent membrane permeable antioxidants that can be used in clinic should be developed for testing in these models. Second, although it has been reported that ISO preconditioning decreases H/R-induced excessive ROS production in the young adult cardiomyocytes (26) and that mitophagy mediates cardiac preconditioning in H/R injury (14, 15) , a direct relationship between improvement of mitophagy and reduction in ROS production after H/R in cardiomyocytes from TEMPOL pretreated old rats has yet to be established. Third, our study addresses only the short-term protection of cardiomyocytes by ISO preconditioning from I/R-or H/R-induced necrotic cell death. Protection from I/R-or H/R-induced other types of cell death and the long-term sequelae, including post I/R cardiac remodeling and function, deserve future attention.
Taken together, our results provide the first evidence that mitophagic/autophagic flux under basal conditions as well as in response to ISO preconditioning is impaired in cardiomyocytes from aged heart and that a 4-week pretreatment of TEMPOL improves it. Inhibition of autophagy by bafilomycin A1 abolished ISO-induced protection in the young cardiomyocytes as well as TEMPOL pretreatment-mediated restoration of ISO preconditioning in the old cardiomyocytes showing that autophagy is essential, at least in vitro. These findings may explain why cardiac preconditioning fails in some clinical settings (1) . Most clinical studies involve patients with pathologies, such as diabetes and advanced age, in which mitochondrial dysfunction figures prominently; these conditions are known to interfere with mitophagy (54, 55) . Our results suggest that strategies can be developed to re-establish pharmacologic cardioprotection in the elderly people during the perioperative period, as well as open new avenues for discovery of novel or improved cardioprotective therapeutics targeting the mitophagic machinery and its regulators.
